The Transcription Factor B-Myb Is Maintained in an Inhibited State in Target Cells through Its Interaction with the Nuclear Corepressors N-CoR and SMRT

REFERENCES

• Ansieau, S., E. Kowenz-Leutz, R. Dechend, and A. Leutz. 1997. B-Myb, a repressed trans-activating protein. J. Mol. Med. 75: 815–819.
   PubMed Web of Science ®Google Scholar
• Arsura, M., M. Introna, F. Passerini, A. Mantovani, and J. Golay. 1992. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood 79: 2708–2716.
   PubMed Web of Science ®Google Scholar
• Asahara, H., S. Dutta, H. Y. Kao, R. M. Evans, and M. Montminy. 1999. Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol. Cell. Biol. 19: 8219–8225.
   PubMedGoogle Scholar
• Bailey, P., M. Downes, P. Lau, J. Harris, S. L. Chen, Y. Hamamori, V. Sartorelli, and G. E. Muscat. 1999. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol. Endocrinol. 13: 1155–1168.
   PubMedGoogle Scholar
• Bartsch, O., S. Horstmann, K. Toprak, K. H. Klempnauer, and S. Ferrari. 1999. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb. Eur. J. Biochem. 260: 384–391.
   PubMedGoogle Scholar
• Bessa, M., M. K. Saville, and R. J. Watson. 2001. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator. Oncogene 20: 3376–3386.
   PubMedGoogle Scholar
• Bies, J., B. Hoffman, A. Amanullah, T. Giese, and L. Wolff. 1996. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 12: 355–363.
   PubMedGoogle Scholar
• Chang, C., J. D. Norris, H. Gron, L. A. Paige, P. T. Hamilton, D. J. Kenan, D. Fowlkes, and D. P. McDonnell. 1999. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol. Cell. Biol. 19: 8226–8239.
   PubMed Web of Science ®Google Scholar
• Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454–457.
   PubMed Web of Science ®Google Scholar
• Choi, C. Y., Y. M. Lee, Y. H. Kim, T. Park, B. H. Jeon, R. A. Schulz, and Y. Kim. 1999. The homeodomain transcription factor NK-4 acts as either a transcriptional activator or repressor and interacts with the p300 coactivator and the Groucho corepressor. J. Biol. Chem. 274: 31543–31552.
   PubMedGoogle Scholar
• Cohen, R. N., F. E. Wondisford, and A. N. Hollenberg. 1998. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements. Mol. Endocrinol. 12: 1567–1581.
   PubMedGoogle Scholar
• Foos, G., S. Natour, and K. H. Klempnauer. 1993. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins. Oncogene 8: 1775–1782.
   PubMedGoogle Scholar
• Heinzel, T., R. M. Lavinsky, T. M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W. M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43–48.
   PubMed Web of Science ®Google Scholar
• Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397–404.
   PubMed Web of Science ®Google Scholar
• Hu, X., and M. A. Lazar. 2000. Transcriptional repression by nuclear hormone receptors. Trends Endocrinol. Metab. 11: 6–10.
   PubMed Web of Science ®Google Scholar
• Jepsen, K., O. Hermanson, T. M. Onami, A. S. Gleiberman, V. Lunyak, R. J. McEvilly, R. Kurokawa, V. Kumar, F. Liu, E. Seto, S. M. Hedrick, G. Mandel, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2000. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102: 753–763.
   PubMedGoogle Scholar
• Johnson, T. K., R. E. Schweppe, J. Septer, and R. E. Lewis. 1999. Phosphorylation of B-Myb regulates its transactivation potential and DNA binding. J. Biol. Chem. 274: 36741–36749.
   PubMed Web of Science ®Google Scholar
• Lam, E. W., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12: 2705–2713.
   PubMed Web of Science ®Google Scholar
• Lane, S., P. Farlie, and R. Watson. 1997. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation. Oncogene 14: 2445–2453.
   PubMedGoogle Scholar
• Lavinsky, R. M., K. Jepsen, T. Heinzel, J. Torchia, T. M. Mullen, R. Schiff, A. L. Del-Rio, M. Ricote, S. Ngo, J. Gemsch, S. G. Hilsenbeck, C. K. Osborne, C. K. Glass, M. G. Rosenfeld, and D. W. Rose. 1998. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA 95: 2920–2925.
   PubMed Web of Science ®Google Scholar
• Lin, D., M. Fiscella, P. M. O'Connor, J. Jackman, M. Chen, L. L. Luo, A. Sala, S. Travali, E. Appella, and W. E. Mercer. 1994. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. Proc. Natl. Acad. Sci. USA 91: 10079–10083.
   PubMedGoogle Scholar
• Lin, D., M. T. Shields, S. J. Ullrich, E. Appella, and W. E. Mercer. 1992. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl. Acad. Sci. USA 89: 9210–9214.
   PubMedGoogle Scholar
• Marhamati, D. J., and G. E. Sonenshein. 1996. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes. J. Biol. Chem. 271: 3359–3365.
   PubMedGoogle Scholar
• Nakagoshi, H., C. Kanei-Ishii, T. Sawazaki, G. Mizuguchi, and S. Ishii. 1992. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7: 1233–1240.
   PubMed Web of Science ®Google Scholar
• Ness, S. A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59: 1115–1125.
   PubMed Web of Science ®Google Scholar
• Oh, I. H., and E. P. Reddy. 1999. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 18: 3017–3033.
   PubMed Web of Science ®Google Scholar
• Sala, A., A. De Luca, A. Giordano, and C. Peschle. 1996. The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity. J. Biol. Chem. 271: 28738–28740.
   PubMedGoogle Scholar
• Sala, A., M. Kundu, I. Casella, A. Engelhard, B. Calabretta, L. Grasso, M. G. Paggi, A. Giordano, R. J. Watson, K. Khalili, and C. Peschle. 1997. Activation of human B-MYB by cyclins. Proc. Natl. Acad. Sci. USA 94: 532–536.
   PubMed Web of Science ®Google Scholar
• Sala, A., and R. Watson. 1999. B-Myb protein in cellular proliferation, transcription control, and cancer: latest developments. J. Cell. Physiol. 179: 245–250.
   PubMedGoogle Scholar
• Saleh, M., I. Rambaldi, X. J. Yang, and M. S. Featherstone. 2000. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. Mol. Cell. Biol. 20: 8623–8633.
   PubMedGoogle Scholar
• Saville, M. K., and R. J. Watson. 1998. B-Myb: a key regulator of the cell cycle. Adv. Cancer Res. 72: 109–140.
   PubMed Web of Science ®Google Scholar
• Saville, M. K., and R. J. Watson. 1998. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties. Oncogene 17: 2679–2689.
   PubMed Web of Science ®Google Scholar
• Shi, Y., M. Downes, W. Xie, H. Y. Kao, P. Ordentlich, C. C. Tsai, M. Hon, and R. M. Evans. 2001. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev. 15: 1140–1151.
   PubMed Web of Science ®Google Scholar
• van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050–2054.
   PubMed Web of Science ®Google Scholar
• Wagner, B. L., J. D. Norris, T. A. Knotts, N. L. Weigel, and D. P. McDonnell. 1998. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol. Cell. Biol. 18: 1369–1378.
   PubMed Web of Science ®Google Scholar
• Watson, R. J., C. Robinson, and E. W. Lam. 1993. Transcription regulation by murine B-myb is distinct from that by c-myb. Nucleic Acids Res. 21: 267–272.
   PubMed Web of Science ®Google Scholar
• Ziebold, U., O. Bartsch, R. Marais, S. Ferrari, and K. H. Klempnauer. 1997. Phosphorylation and activation of B-Myb by cyclin A-Cdk2. Curr. Biol. 7: 253–260.
   PubMed Web of Science ®Google Scholar